Introducing the Nobivac® NXT generation of vaccine technology

Client
Merck Animal Health

Project
Nobivac® NXT launch campaign

What was the challenge?

Merck Animal Health came to us with an exciting opportunity: to help introduce the North American market to the next big thing in vaccine technology—Nobivac® NXT (pronounced next), the first and only companion animal vaccines in the US to use revolutionary RNA particle technology. Starting with the launch of Nobivac® NXT Canine Flu H3N2, our challenge was twofold: introduce the new Nobivac® NXT platform and overcome both the novelty of the technology and the market’s familiarity and comfort level with vaccines during a time of heightened post-pandemic vaccine skepticism. The challenge continued with the launch of Nobivac® NXT FeLVwhich joined an already well-established traditional vaccine from Merck. So how did we educate veterinarians about the new platform and the innovative technology behind these lowvolume, non-adjuvanted vaccines while generating enthusiasm for the protection they deliver? We took it to the next level, of course. 

How did we solve it?

To educate and inspire our audience, we crafted a sleek, modern design that reflects the minimal materials used in Nobivac® NXT vaccines. Bold molecular graphics—drawing from the signature colored dots of the Nobivac brandhighlight its cutting-edge RNA particle technology. Educational materials simplified the complex science while emphasizing the benefits of next-level protection for pets. This innovative campaign won a Silver medal in the Product Launch (Campaign) category at the 2024 Vetty Awards®, celebrating a remarkable milestone for the brand. What’s next for Nobivac® NXT? The sky’s the limit! 

What we delivered

  • Educational videos 
  • Website landing and product pages 
  • Digital detailer 
  • Lunch-and-learn presentation 
  • One-page overview sheets  
  • Launch announcement emails 
  • Educational presentations for Merck’s Professional Service Veterinarians 
  • Print and digital media assets 
Circa Logo

Introducing the Nobivac® NXT generation of vaccine technology

Client
Merck Animal Health

Project
Nobivac® NXT launch campaign

What was the challenge?

Merck Animal Health came to us with an exciting opportunity: to help introduce the North American market to the next big thing in vaccine technology—Nobivac® NXT (pronounced next), the first and only companion animal vaccines in the US to use revolutionary RNA particle technology. Starting with the launch of Nobivac® NXT Canine Flu H3N2, our challenge was twofold: introduce the new Nobivac® NXT platform and overcome both the novelty of the technology and the market’s familiarity and comfort level with vaccines during a time of heightened post-pandemic vaccine skepticism. The challenge continued with the launch of Nobivac® NXT FeLVwhich joined an already well-established traditional vaccine from Merck. So how did we educate veterinarians about the new platform and the innovative technology behind these lowvolume, non-adjuvanted vaccines while generating enthusiasm for the protection they deliver? We took it to the next level, of course. 

How did we solve it?

To educate and inspire our audience, we crafted a sleek, modern design that reflects the minimal materials used in Nobivac® NXT vaccines. Bold molecular graphics—drawing from the signature colored dots of the Nobivac brandhighlight its cutting-edge RNA particle technology. Educational materials simplified the complex science while emphasizing the benefits of next-level protection for pets. This innovative campaign won a Silver medal in the Product Launch (Campaign) category at the 2024 Vetty Awards®, celebrating a remarkable milestone for the brand. What’s next for Nobivac® NXT? The sky’s the limit! 

What we delivered

  • Educational videos 
  • Website landing and product pages 
  • Digital detailer 
  • Lunch-and-learn presentation 
  • One-page overview sheets  
  • Launch announcement emails 
  • Educational presentations for Merck’s Professional Service Veterinarians 
  • Print and digital media assets 
We use cookies to analyze traffic and improve your experience. Learn more in our Cookie and Privacy Policy.